{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:07:59Z","timestamp":1782486479363,"version":"3.54.5"},"publisher-location":"Chichester, UK","reference-count":16,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008907.pub2","type":"reference-entry","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T21:52:08Z","timestamp":1323121928000},"source":"Crossref","is-referenced-by-count":9,"title":["Eslicarbazepine acetate add-on for drug-resistant partial epilepsy"],"prefix":"10.1002","author":[{"given":"Xian-Chao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"key":"10.1002\/14651858.CD008907.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eplepsyres.2010.01.014","article-title":"Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy","volume":"89","author":"Ben-Menachem","year":"2010","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD008907.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1528-1167.2007.00984.x","article-title":"Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures","volume":"48","author":"Elger","year":"2007","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD008907.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1528-1167.2008.01946.x","article-title":"Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study","volume":"50","author":"Elger","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD008907.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2009.01218.x","article-title":"Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures","volume":"120","author":"Gil-Nagel","year":"2009","journal-title":"Acta Neurologica Scandinavica"},{"issue":"10","key":"10.1002\/14651858.CD008907.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/j.1528-1167.2010.02660.x","article-title":"Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy","volume":"51","author":"Hal\u00e1sz","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD008907.pub2-BIB6|cit6","unstructured":"Nunes T Efficacy and safety of eslicarbazepine acetate (BIA 2-093) as adjunctive therapy for refractory partial seizures in a double-blind, randomised, placebo-controlled, parallel-group, multicentre trial"},{"key":"10.1002\/14651858.CD008907.pub2-BIB7|cit7","unstructured":"Nunes T Efficacy and safety study of eslicarbazepine acetate (BIA 2 093) as adjunctive therapy for refractory partial seizures in children"},{"key":"10.1002\/14651858.CD008907.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nurt.2006.10.005","article-title":"Eslicarbazepine acetate (BIA 2-093)","volume":"4(1)","author":"Almeida","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1002\/14651858.CD008907.pub2-BIB9|cit9","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009] The Cochrane Collaboration 2009","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD008907.pub2-BIB10|cit10","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD008907.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/0023210-200923010-00005","article-title":"Eslicarbazepine acetate","volume":"23","author":"McCormack","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD008907.pub2-BIB12|cit12","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models","author":"McCullagh","year":"1989"},{"issue":"2","key":"10.1002\/14651858.CD008907.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/13543780802635107","article-title":"Eslicarbazepine acetate: a new option for the treatment of focal epilepsy","volume":"18","author":"Mestre","year":"2009","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"2","key":"10.1002\/14651858.CD008907.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00019052-200304000-00008","article-title":"The epidemiology of epilepsy revisited","volume":"16","author":"Sander","year":"2003","journal-title":"Current Opinion in Neurology"},{"issue":"6","key":"10.1002\/14651858.CD008907.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1474-4422(08)70108-X","article-title":"Intractable epilepsy: management and therapeutic alternatives","volume":"7","author":"Schuele","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD008907.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/WNL.49.2.333","article-title":"Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs","volume":"49(2)","author":"Walker","year":"1997","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008907.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T00:00:00Z","timestamp":1508889600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008907.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:25:09Z","timestamp":1628547909000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008907.pub2"}},"subtitle":[],"editor":[{"given":"Rong-Yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":16,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008907.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD008907.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2011,12,7]]}}}